Skip to main content
. 2024 Jan 5;58(1):22–29. doi: 10.26650/eor.20231260787

Table 3.

Evaluation of the hematoxylin-eosin criteria results for all groups on day 7th, 15th and 30th. In the horizontal column, the same capital letters indicate the difference between the groups, and in the vertical column, the same lowercase letters indicate the difference between the groups (*p less than 0.05).

KE KV EE EV CONTROL
Parameters Time Mean Min-max. Mean Min-max. Mean Min-max. Mean Min-max. Mean Min-max. p
7 1.16A,D,E,F 1-2 1.83B,D,G,a 1-2 2.16C,E,a,b 2-3 3.00F,G,H,a,b 3-3 0.83A,B,C,H 0-1 0.001*
Inflammation 15 1.00B 0-2 1.33 1-2 1.33a 1-2 2.00A.B.a 1-3 0.66A 0-1 0.017*
30 0.54 0-1 0.83a 0-1 0.83b 0-1 1.16b 1-2 0.50 0-1 0.129
p 0.057 0.034* 0.023* 0.020* 0.157
7 1.16a 1-2 1.00a,b 1-1 1.50 1-2 1.16a,b 1-2 1.16a 1-2 0.305
Fibrous Capsule 15 1.66 1-2 2.00a 2-2 1.66 1-2 2.00a 2-2 1.5 1-2 0.166
30 2.00a 2-2 2.00b 2-2 2.00 2-2 2.00b 2-2 2.00a 2-2 1.00
p 0.025* 0.014* 0.83 0.025* 0.025*
7 0.16 0-1 0.33 0-1 0.33 0-1 0.5 0-1 0.16 0-1 0.709
Necrosis 15 0 0 0 0 0 0 0.16 0 0 0 1.00
30 0 0 0 0 0 0 0 0 0 0 1.00
p 0.317 0.157 0.157 0.083 0.317
7 1.00a 1-1 1.00a 1-1 1.00 1-1 1.00 1-1 1.00a 1-1 1.00
Giant Cell 15 0.66 0-1 0.66 0-1 0.83 0-1 1.00 0-1 0.66 0-1 0.578
30 0.16B,a 0-1 0.16A,a 0-1 0.50 0-1 1.00A,B,C 0-1 0.33C,a 0-1 0.024*
p 0.025* 0.025* 0.157 0.046*
7 1.83D,a 1-2 2.1A,a 2-3 2.33B,a 2-3 2.66C,D,a,b 2-3 1.16A,B,C 1-2 0.02*
Macrophage Infiltrate 15 1.16D,E 1-2 1.5A 1-2 2.00B,D,b 2-2 2.00C,E,a 2-2 1.00A,B,C 1-1 0.001*
30 1.00A,D,a 1-1 1.16a 1-2 1.00B,a,b 1-1 1.5A,B,C,D,b 1-2 1.00C 1-1 0.048*
p 0.034* 0.014* 0.023* 0.046*